Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy

American Journal of Medical Genetics, Part A - Tập 136A Số 2 - Trang 117-121 - 2005
Kirsten D. Loureiro1, Kelly Kao2, Kenneth Lyons Jones2, Sonia Alvarado2, Carmen Chavez2, Lyn M. Dick2, Robert J. Felix2, Diana Johnson2, Christina Chambers3,2
1Graduate School of Public Health, San Diego State University, San Diego, California
2Department of Pediatrics, Division of Dysmorphology and Teratology, University of California–San Diego, La Jolla, California
3Department of Family and Preventive Medicine, Division of Epidemiology, University of California, San Diego, La Jolla, California

Tóm tắt

AbstractTopical tretinoin (Retin‐A®) is used to treat acne and photodamaged skin. Its teratogenic potential is of concern due to its similarity to isotretinoin (Accutane®), a recognized human teratogen. Through the California Teratogen Information Service and Clinical Research Program, between 1983 and 2003, 106 pregnant women with first‐trimester exposure to topical tretinoin were prospectively ascertained and followed. Birth outcomes, including pregnancy loss, major structural defects, and pre‐ and postnatal growth were compared to 389 similarly and prospectively ascertained women with no topical tretinoin exposure during pregnancy. Because a distinct pattern of malformation had already been described for isotretinoin, we also compared exposed (n = 62) and unexposed (n = 191) infants on the prevalence of a specific subset of minor malformations selected to represent the spectrum of defects comprising the retinoic acid embyopathy. There were no significant differences between groups in the proportion of pregnancies ending in spontaneous abortion (6.6% in exposed vs. 8.5% in unexposed; P = 0.53), or infants with major structural defects (2.2% in exposed vs. 1.2% in unexposed; P = 0.62). In addition, the groups were similar in birth weight, length and head circumference, and there were no significant differences between groups in length of gestation. Furthermore, the prevalence of one or more retinoic acid‐specific minor malformations did not differ significantly between groups (12.9% in exposed vs. 9.9% in unexposed; P = 0.51). First‐trimester topical tretinoin exposure in this study was not associated with an increased risk of any adverse pregnancy outcome evaluated. Specifically, there was no indication that topical tretinoin is associated with an increased risk for minor malformations that are consistent with the retinoic acid embryopathy. Although it is impossible to exclude the possibility that some women/infants may be uniquely susceptible to topical tretinoin exposure, this study provides further reassurance for women who are inadvertently exposed early in pregnancy. © 2005 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/0890-6238(93)90273-A

10.1016/S0190-9622(94)70051-6

10.1016/0140-6736(92)90854-V

10.1002/bdrb.20015

10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO;2-L

10.1016/S0378-4347(00)81482-6

Franz TJ, 1993, Topical use of retinoic acid gel is not teratogenic, Journal of Investigative Dermatology, 100, 490

Hollingshead AB, 1965, Four factor index of social position

10.1016/0190-9622(91)70065-A

10.1016/0140-6736(93)91004-6

10.1002/tera.10023

Kuczmarski RJ, 2000, CDC growth charts: United States: Vol. 314

LammerEJ.Personal communication.2004.

10.1056/NEJM198510033131401

10.1016/0140-6736(93)90868-H

Lubchenko L, 1966, Pediatrics, 37, 403, 10.1542/peds.37.3.403

10.1002/(SICI)1096-9926(199907)60:1<5::AID-TERA3>3.0.CO;2-#

10.1345/aph.17138

Schaefer H, 1975, Penetration of vitamin A acid into human skin, Acta Dermato‐Venereologica (Stockh), 74, 50

10.1016/0890-6238(90)90039-X

10.1016/S0190-9622(97)70061-6

10.1016/S0387-7604(00)00104-2

10.1016/S0140-6736(05)63790-7

10.1002/tera.1420510605

10.1111/1523-1747.ep12504873

Worobec SM, 1991, Percutaneous absorption of 3H‐tretinoin in normal volunteers. (abstract), J Invest Dermatol, 96, 574A

Thông tin
Thông tin xuất bản

American Journal of Medical Genetics, Part A

Tập 136A Số 2

117-121

Thông tin tác giả